1. Home
  2. PRAX vs FSS Comparison

PRAX vs FSS Comparison

Compare PRAX & FSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$282.31

Market Cap

7.1B

Sector

Health Care

ML Signal

HOLD

Logo Federal Signal Corporation

FSS

Federal Signal Corporation

HOLD

Current Price

$118.52

Market Cap

6.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAX
FSS
Founded
2015
1901
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
6.6B
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
PRAX
FSS
Price
$282.31
$118.52
Analyst Decision
Strong Buy
Buy
Analyst Count
15
4
Target Price
$572.13
$131.75
AVG Volume (30 Days)
475.2K
413.4K
Earning Date
05-08-2026
04-29-2026
Dividend Yield
N/A
0.46%
EPS Growth
N/A
14.57
EPS
N/A
1.14
Revenue
N/A
$2,180,500,000.00
Revenue This Year
N/A
$20.94
Revenue Next Year
$7,758.26
$6.79
P/E Ratio
N/A
$103.72
Revenue Growth
N/A
17.14
52 Week Low
$37.25
$100.43
52 Week High
$366.52
$132.89

Technical Indicators

Market Signals
Indicator
PRAX
FSS
Relative Strength Index (RSI) 47.14 63.08
Support Level $238.77 $115.41
Resistance Level $342.62 $119.69
Average True Range (ATR) 21.47 3.00
MACD 0.62 1.08
Stochastic Oscillator 39.34 95.75

Price Performance

Historical Comparison
PRAX
FSS

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About FSS Federal Signal Corporation

Federal Signal Corp designs and manufactures products and integrated solutions for municipal, governmental, industrial, and airport customers. It operates through two segments. The Environmental Solutions Group manufactures and supplies street sweeper vehicles, sewer cleaner and vacuum loader trucks, hydro-excavation trucks, high-performance water blasting equipment, dump truck bodies, and trailers. The Safety and Security Systems Group manufactures and supplies comprehensive systems and products used by law enforcement, fire rescue, and industrial sites to protect people and property. Its offerings include systems for community alerting and industrial communications. The company generates the majority of its revenue from the Environmental Solutions Group segment.

Share on Social Networks: